District Court, E.D. North Carolina September 22, 2017, No. 5:16-CV-313-D (TransEnterix Investor Group v. TransEnterix, Inc.)
Also known as
United States · · · 22-09-2017
'ORDER
JAMES C. DEVER III, Chief United States District Judge
On June 2, 2016, plaintiff TransEnterix Investor Group, individually and on behalf of others similarly situated (collectively, “plaintiffs”), sued TransEnterix, Inc. (“TransEnterix”), two of its officers, several of its directors, and the underwriter of one .of TransEnterix’s securities offerings (collectively, “defendants”) for violations of the Securities Act of 1933 and the Securities Exchange Act of 1934 [D.E. 1]. On September 26, 2016, plaintiffs amended the complaint [D.E. 62], On November 8, 2016, defendants moved to dismiss the amended complaint under Rule 12(b)(6) of the. Federal Rules of Civil Procedure [D.E, 82, 84] and filed memoranda in support [D.E. 83, 85]. On December 22, 2016, plaintiffs responded in opposition [D.E. 88], On January 20, 2017, defendants replied [D.E. 92, 93]. As explained below, the court grants the motions to dismiss.
I.
TransEnterix is a medical-device company that manufactures robotics for use in surgeries. Am. Compl. [D.E. 62] ¶ 3. Among TransEnterix’s products was the robotically enhanced surgical device known as the SurgiBot system (“SurgiBot”). Id. With a price tag of $500,000, SurgiBot was designed as a lower-cost alternative for the surgical-robot industry. Id.
On June 1, 2015, TransEnterix submitted a “510(k) application” for SurgiBot to the Food and Drug Administration (“FDA”). Id. ¶¶ 4, 7. Otherwise known as a “premarket notification,” a 510(k) application gives the FDA 90 days’ notice of a manufacturer’s intent to market a medical device. Id. ¶ 5. During the intervening 90 days, the FDA determines whether the device is “substantially equivalent” to a device already on the market. Id. Until the FDA makes that determination, a manufacturer cannot market the device. Id. ¶ 6.
On July 27, 2015, the FDA hosted a public forum designated “Robotically-As-sisted Surgical Devices: Challenges and Opportunities.” Id. ¶ 28(a).
Read the full text
This document is published by courtlistener.com.
Moonlit adds the citation network, article-level links and cross-references, which are available to search for free.
Sign in to Moonlit